Breakthrough in Obesity Treatment: The Dawn of GLP-1 Implants
Vivani Medical is making significant progress with its innovative GLP-1 (exenatide) implant to combat obesity and potentially type 2 diabetes. The LIBERATE-1 trial has begun in Australia, focusing on the implant’s efficacy, safety, and pharmacokinetics, with results anticipated by mid-2025. The GLP-1
